1. Home
  2. Analysis
  3. Macrobid
  4. Lopressor

Macrobid and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macrobid and Lopressor. Common interactions include rash papular among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people who take Macrobid and Lopressor have. It is created by eHealthMe based on reports of 76 people who take Macrobid and Lopressor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

76 people who take Macrobid and Lopressor together, and have interactions are studied.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 8,337 Macrobid users for its effectiveness, alternative drugs and more.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 32,077 Lopressor users for its effectiveness, alternative drugs and more.

Number of Macrobid and Lopressor reports submitted per year:

Macrobid and Lopressor drug interactions.

Common Macrobid and Lopressor drug interactions by gender *:

female:

  1. Rash papular
  2. Seborrhoeic keratosis
  3. Sinusitis
  4. Skin cancer
  5. Somnolence
  6. Troponin increased
  7. Upper limb fracture
  8. Cardiac murmur
  9. Haemoglobin increased
  10. Surgery

male:

  1. Cellulitis
  2. Chronic kidney disease
  3. Cholecystitis acute
  4. Cholelithiasis
  5. Depression
  6. Emotional distress
  7. Hyperparathyroidism secondary
  8. Malignant melanoma
  9. Nervousness
  10. Pneumonia

Common Macrobid and Lopressor drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abnormal weight gain
  2. Adverse reaction
  3. Anhedonia
  4. Anxiety
  5. Cataract
  6. Chronic sinusitis
  7. Contusion
  8. Deep vein thrombosis
  9. Device expulsion
  10. Drug intolerance

20-29:

  1. Anxiety
  2. Cushingoid
  3. Diarrhoea
  4. Dyspnoea
  5. Headache
  6. Heart rate increased
  7. Joint swelling
  8. Local swelling
  9. Muscular weakness
  10. Pneumonia staphylococcal

30-39:

  1. Calculus bladder
  2. Cardiac disorder
  3. Cataract
  4. Cellulitis
  5. Kidney infection
  6. Nephrolithiasis
  7. Paraplegia
  8. Visual impairment
  9. Anhedonia
  10. Anxiety

40-49:

  1. Abdominal distension
  2. Abdominal pain
  3. Anxiety
  4. Dyspnoea
  5. Fatigue
  6. Gastritis
  7. Haematuria present
  8. Hypokalaemia
  9. Hyponatraemia
  10. Joint swelling

50-59:

  1. Anaemia of chronic disease
  2. Anxiety
  3. Asthenia
  4. Bradycardia
  5. Chest pain
  6. Coronary artery disease
  7. Fluid overload
  8. Multiple injuries
  9. Platelet count decreased
  10. Renal failure acute

60+:

  1. Malaise
  2. Renal failure acute
  3. Fall
  4. Myocardial infarction
  5. Abdominal pain
  6. Multiple injuries
  7. Anxiety
  8. Cardiac failure congestive
  9. Constipation
  10. Dyspnoea

Common conditions people have *:

  1. Pain: 12 people, 15.79%
  2. Stress And Anxiety: 7 people, 9.21%
  3. Depression: 7 people, 9.21%
  4. Constipation: 7 people, 9.21%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.89%
  6. Diabetes: 6 people, 7.89%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 6.58%
  8. Stable Angina (a constant chest pain): 4 people, 5.26%
  9. Sinus Congestion (blockage of sinus): 4 people, 5.26%
  10. Osteoporosis (bones weak and more likely to break): 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Macrobid and Lopressor?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Macrobid and Lopressor interactions:

Browse all drug interactions of Macrobid and Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Macrobid side effects:

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lopressor side effects:

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Macrobid interactions:

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lopressor interactions:

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin; nitrofurantoin, macrocrystalline and metoprolol tartrate (the active ingredients of Macrobid and Lopressor, respectively), and Macrobid and Lopressor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Macrobid and Lopressor.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.